Raha Samraat S.

Raha Samraat S. is listed in filings as President and CEO at Myriad Genetics, Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including purchase activity. Recent filings connect the profile to Myriad Genetics, Inc. (MYGN). The current snapshot covers public activity from Dec 2, 2024 to Mar 16, 2026. Reported amounts are shown as $50.4K to $199.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.